Toru Takiguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Toru Takiguchi has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Shoji Yokobori
Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan
10 shared publicationsTakashi Tagami
Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan
9 shared publicationsTomohisa Seki
Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan
7 shared publicationsJun Nakata
Division of Cardiovascular Intensive Care Nippon Medical School Tokyo Japan
6 shared publicationsNaoki Tominaga
Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan
6 shared publicationsShiei Kim
Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan
6 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (8) , e1447
Early Total Bilirubin Trajectories During the First 72 Hours After ICU Admission With Mechanical Ventilation and Short-Term Mortality: A Multicenter Cohort Study
OBJECTIVES: To determine whether early total bilirubin (T-Bil) trajectories during the first 72 hours after intubation identify trajectory-defined groups with distinct prognostic profiles associated with short-term mortality in mechanically ventilated ICU patients. DESIGN: Multicenter retrospective cohort study with a prespecified day 3 landmark design to mitigate immortal-time bias. SETTING: Mixed medical-surgical ICUs at four tertiary centers. PATIENTS: Adults receiving invasive mechanical ventilation who survived to the day 3 landmark and had serial T-Bil measurements on day 0 and day 3 (± 24 hr). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were classified according to baseline T-Bil (≤ 1.2 vs. > 1.2 mg/dL) and the direction of change between day 0 and day 3 (change in T-Bil [ΔT-Bil]), yielding four trajectory-defined groups. The primary outcome was 30-day all-cause mortality after the day 3 landmark; 90-day mortality was secondary. Conditional survival was assessed using Kaplan-Meier methods with log-rank tests. Multivariable Cox models adjusted for prespecified covariates available by day 3 (age, sex, body mass index, intubating department, baseline mean arterial pressure, log-transformed aspartate aminotransferase/alanine aminotransferase ratio and platelet count, creatinine, renal replacement therapy, and vasoactive support). Rising T-Bil trajectories were independently associated with higher 30-day mortality, with the strongest association among patients with normal baseline T-Bil who exhibited early increases. In contrast, elevated baseline T-Bil followed by early decline was not associated with excess risk. Findings were consistent in complete-case analyses, in models incorporating day 3 partial Sequential Organ Failure Assessment for severity adjustment, and in analyses of 90-day mortality. Restricted cubic spline analyses demonstrated a nonlinear dose-response relationship between ΔT-Bil and mortality. CONCLUSIONS: Early T-Bil dynamics within 72 hours after intubation were associated with distinct prognostic profiles beyond baseline bilirubin levels and may provide a pragmatic marker for early risk stratification in mechanically ventilated ICU patients.
- 5 August 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (8) , e1447
Open AccessEarly Total Bilirubin Trajectories During the First 72 Hours After ICU Admission With Mechanical Ventilation and Short-Term Mortality: A Multicenter Cohort Study
OBJECTIVES: To determine whether early total bilirubin (T-Bil) trajectories during the first 72 hours after intubation identify trajectory-defined groups with distinct prognostic profiles associated with short-term mortality in mechanically ventilated ICU patients. DESIGN: Multicenter retrospective cohort study with a prespecified day 3 landmark design to mitigate immortal-time bias. SETTING: Mixed medical-surgical ICUs at four tertiary centers. PATIENTS: Adults receiving invasive mechanical ventilation who survived to the day 3 landmark and had serial T-Bil measurements on day 0 and day 3 (± 24 hr). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were classified according to baseline T-Bil (≤ 1.2 vs. > 1.2 mg/dL) and the direction of change between day 0 and day 3 (change in T-Bil [ΔT-Bil]), yielding four trajectory-defined groups. The primary outcome was 30-day all-cause mortality after the day 3 landmark; 90-day mortality was secondary. Conditional survival was assessed using Kaplan-Meier methods with log-rank tests. Multivariable Cox models adjusted for prespecified covariates available by day 3 (age, sex, body mass index, intubating department, baseline mean arterial pressure, log-transformed aspartate aminotransferase/alanine aminotransferase ratio and platelet count, creatinine, renal replacement therapy, and vasoactive support). Rising T-Bil trajectories were independently associated with higher 30-day mortality, with the strongest association among patients with normal baseline T-Bil who exhibited early increases. In contrast, elevated baseline T-Bil followed by early decline was not associated with excess risk. Findings were consistent in complete-case analyses, in models incorporating day 3 partial Sequential Organ Failure Assessment for severity adjustment, and in analyses of 90-day mortality. Restricted cubic spline analyses demonstrated a nonlinear dose-response relationship between ΔT-Bil and mortality. CONCLUSIONS: Early T-Bil dynamics within 72 hours after intubation were associated with distinct prognostic profiles beyond baseline bilirubin levels and may provide a pragmatic marker for early risk stratification in mechanically ventilated ICU patients.
- Open Access
- 3 February 2026
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 40 (3) , 621-633
Early heart-rate trajectory phenotypes predict short-term mortality in critically ill patients: a dynamic time-warping cluster analysis
Heart rate (HR) reflects illness severity in critically ill patients, but the prognostic significance of early HR changes is unclear. We aimed to identify HR trajectory phenotypes during the first 24 h of ICU admission and assess their association with short-term mortality. Adults admitted to the intensive care unit (ICU) between January 2018 and December 2024 with ≥ 12 h of HR data were eligible; patients with early discharge/death, mechanical support, or sustained bradycardia were excluded. Hourly HR means from the first 24 h were imputed and clustered via Dynamic Time Warping-based TimeSeriesKMeans; five trajectories were selected using internal validation. Thirty- and 90-day mortality were assessed by multivariable Cox models. A total of 4491 patients were analyzed after applying exclusion criteria. TimeSeriesKMeans identified five early HR trajectory phenotypes: Cluster A (persistently tachycardic), Cluster B (early HR normalization), Cluster C (rising HR), Cluster D (mild tachycardic-normal), and Cluster E (normal HR). Cluster A was associated with a markedly increased risk of 30-day mortality compared with the reference Cluster E (HR 3.21, 95% CI 2.32–4.45; p < 0.001). Cluster C also showed an elevated mortality risk (HR 2.09, 95% CI 1.53–2.85; p < 0.001), whereas clusters characterized by lower or early-normalizing heart-rate trajectories demonstrated more favorable survival profiles. Kaplan-Meier analyses confirmed significant differences in survival across clusters (log-rank p < 0.001). Machine learning-based phenotyping of 24-hour HR trajectories stratified short-term mortality risk and revealed time-dependent patterns potentially reflecting treatment responsiveness. Early adverse heart-rate trajectories, particularly persistent tachycardia, may serve as prognostic signals of physiological stress or poor treatment response during the initial ICU course, supporting early risk stratification and clinical reassessment.
- 3 February 2026
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 40 (3) , 621-633
Open AccessEarly heart-rate trajectory phenotypes predict short-term mortality in critically ill patients: a dynamic time-warping cluster analysis
Heart rate (HR) reflects illness severity in critically ill patients, but the prognostic significance of early HR changes is unclear. We aimed to identify HR trajectory phenotypes during the first 24 h of ICU admission and assess their association with short-term mortality. Adults admitted to the intensive care unit (ICU) between January 2018 and December 2024 with ≥ 12 h of HR data were eligible; patients with early discharge/death, mechanical support, or sustained bradycardia were excluded. Hourly HR means from the first 24 h were imputed and clustered via Dynamic Time Warping-based TimeSeriesKMeans; five trajectories were selected using internal validation. Thirty- and 90-day mortality were assessed by multivariable Cox models. A total of 4491 patients were analyzed after applying exclusion criteria. TimeSeriesKMeans identified five early HR trajectory phenotypes: Cluster A (persistently tachycardic), Cluster B (early HR normalization), Cluster C (rising HR), Cluster D (mild tachycardic-normal), and Cluster E (normal HR). Cluster A was associated with a markedly increased risk of 30-day mortality compared with the reference Cluster E (HR 3.21, 95% CI 2.32–4.45; p < 0.001). Cluster C also showed an elevated mortality risk (HR 2.09, 95% CI 1.53–2.85; p < 0.001), whereas clusters characterized by lower or early-normalizing heart-rate trajectories demonstrated more favorable survival profiles. Kaplan-Meier analyses confirmed significant differences in survival across clusters (log-rank p < 0.001). Machine learning-based phenotyping of 24-hour HR trajectories stratified short-term mortality risk and revealed time-dependent patterns potentially reflecting treatment responsiveness. Early adverse heart-rate trajectories, particularly persistent tachycardia, may serve as prognostic signals of physiological stress or poor treatment response during the initial ICU course, supporting early risk stratification and clinical reassessment.
- Open Access
- 7 August 2025
- Published by IOS Press
- Vol. 329, 603-607
Assessment of Medically Relevant Ageism Inherent in Large Language Models
As the global population ages, the importance of reducing or eliminating social agism increases. However, although the medical field is known to be pervasive in terms of ageism against the older people, such assessments have not yet been conducted in terms of equity in large language models (LLMs). In this study, we created a dataset to assess the potential for medically related ageism among LLMs and attempted to visualize it. These results suggest that many LLMs exhibit stereotypical ageism in terms of reluctance to intervene in treatment and self-ageism. These results indicate the importance of developing a framework to avoid or reduce ageism in the social implementation of LLMs in the medical field.
- 7 August 2025
- Published by IOS Press
- Vol. 329, 603-607
Open AccessAssessment of Medically Relevant Ageism Inherent in Large Language Models
As the global population ages, the importance of reducing or eliminating social agism increases. However, although the medical field is known to be pervasive in terms of ageism against the older people, such assessments have not yet been conducted in terms of equity in large language models (LLMs). In this study, we created a dataset to assess the potential for medically related ageism among LLMs and attempted to visualize it. These results suggest that many LLMs exhibit stereotypical ageism in terms of reluctance to intervene in treatment and self-ageism. These results indicate the importance of developing a framework to avoid or reduce ageism in the social implementation of LLMs in the medical field.
- Open Access
- 15 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Transfusion ratios and survival in severe blunt trauma patients receiving massive transfusion
The optimal transfusion ratios for severe blunt trauma requiring massive transfusion remain unclear. This nationwide retrospective cohort study used data from the Japan Trauma Data Bank (2019–2022) and included patients receiving ≥ 10 units of packed red blood cells (pRBC) within 24 h. The fresh frozen plasma (FFP)-to-pRBC and platelet concentrate (PC)-to-pRBC ratios were categorized as 0–0.5, 0.5–1, 1–1.5, 1.5–2, and > 2. Among 2,849 eligible patients, an FFP-to-pRBC ratio of 1–1.5 was associated with significantly higher in-hospital survival than 0.5–1 (adjusted odds ratio [OR], 1.46; 95% confidence interval [CI], 1.12–1.92; P = 0.006). A PC-to-pRBC ratio of 1.5–2 also showed a trend toward improved survival (1.62; 1.00–2.69; P = 0.053). Patients were categorized into three phenotypes: truncal trauma with shock (70.3%), moderate head and extremity trauma (11.8%), and severe head trauma with consciousness disturbances (17.9%). In the truncal trauma with shock phenotype, FFP-to-pRBC ratios of 1–1.5 (1.56; 1.12–2.20; P = 0.010) and > 2 (2.32; 1.14–5.10; P = 0.027) were associated with improved survival. Higher FFP-to-pRBC and PC-to-pRBC ratios may be associated with improved survival, especially in truncal trauma with shock.
- 15 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessTransfusion ratios and survival in severe blunt trauma patients receiving massive transfusion
The optimal transfusion ratios for severe blunt trauma requiring massive transfusion remain unclear. This nationwide retrospective cohort study used data from the Japan Trauma Data Bank (2019–2022) and included patients receiving ≥ 10 units of packed red blood cells (pRBC) within 24 h. The fresh frozen plasma (FFP)-to-pRBC and platelet concentrate (PC)-to-pRBC ratios were categorized as 0–0.5, 0.5–1, 1–1.5, 1.5–2, and > 2. Among 2,849 eligible patients, an FFP-to-pRBC ratio of 1–1.5 was associated with significantly higher in-hospital survival than 0.5–1 (adjusted odds ratio [OR], 1.46; 95% confidence interval [CI], 1.12–1.92; P = 0.006). A PC-to-pRBC ratio of 1.5–2 also showed a trend toward improved survival (1.62; 1.00–2.69; P = 0.053). Patients were categorized into three phenotypes: truncal trauma with shock (70.3%), moderate head and extremity trauma (11.8%), and severe head trauma with consciousness disturbances (17.9%). In the truncal trauma with shock phenotype, FFP-to-pRBC ratios of 1–1.5 (1.56; 1.12–2.20; P = 0.010) and > 2 (2.32; 1.14–5.10; P = 0.027) were associated with improved survival. Higher FFP-to-pRBC and PC-to-pRBC ratios may be associated with improved survival, especially in truncal trauma with shock.
- Open Access
- 6 May 2025
- Published by Springer Nature in Research Square
Transfusion Ratios of Fresh Frozen Plasma and Platelet Concentrate to Packed Red Blood Cells in Patients with Severe Blunt Trauma Receiving Massive Transfusion: A Nationwide Retrospective Cohort Study
Background The efficacy and optimal transfusion ratios of fresh frozen plasma (FFP), platelet concentrate (PC), and packed red blood cells (pRBC) exceeding 1:1:1 in patients with severe blunt trauma receiving massive transfusion, as well as the optimal ratios for specific trauma phenotypes, remain unknown. Methods We conducted a nationwide retrospective cohort study using data from the Japan Trauma Data Bank (January 2019 and December 2022). The final study population consisted of patients who received massive transfusions following blunt trauma, defined as the administration of ≥ 10 units of pRBC within 24 hours. The FFP-to-pRBC and PC-to-pRBC ratios were categorised as 0–0.5, 0.5–1, 1–1.5, 1.5–2, and > 2. Multivariate logistic regression analysis was performed to analyse the association between these ratios and in-hospital survival rates. Unsupervised agglomerative clustering was used to identify distinct clinical phenotypes. Results Among 2,849 eligible patients, an FFP-to-pRBC ratio of 1–1.5 was associated with significantly higher in-hospital survival compared to a ratio of 0.5–1 (adjusted odds ratio [OR] = 1.46; 95% confidence interval [CI], 1.12–1.92; P = 0.006). Similarly, a PC-to-pRBC ratio of 1.5–2 was associated with higher survival compared to a ratio of 0.5–1 (adjusted OR = 1.62; 95% CI, 1.00–2.69; P = 0.053). Patients were categorized into three phenotypes: truncal trauma with shock (70.3%), moderate head and extremity trauma (11.8%), and severe head trauma with consciousness disturbances (17.9%). In the truncal trauma with shock phenotype, FFP-to-pRBC ratios of 1–1.5 (adjusted OR = 1.56; 95% CI, 1.12–2.20; P = 0.010) and > 2 (adjusted OR = 2.32; 95% CI, 1.14–5.10; P = 0.027) were associated with improved survival. Conclusions Higher FFP-to-pRBC (1–1.5) and PC-to-pRBC (1.5–2) ratios were associated with improved survival. Higher FFP-to-pRBC ratios were particularly beneficial for truncal trauma with shock phenotype.
- 6 May 2025
- Published by Springer Nature in Research Square
Open AccessTransfusion Ratios of Fresh Frozen Plasma and Platelet Concentrate to Packed Red Blood Cells in Patients with Severe Blunt Trauma Receiving Massive Transfusion: A Nationwide Retrospective Cohort Study
Background The efficacy and optimal transfusion ratios of fresh frozen plasma (FFP), platelet concentrate (PC), and packed red blood cells (pRBC) exceeding 1:1:1 in patients with severe blunt trauma receiving massive transfusion, as well as the optimal ratios for specific trauma phenotypes, remain unknown. Methods We conducted a nationwide retrospective cohort study using data from the Japan Trauma Data Bank (January 2019 and December 2022). The final study population consisted of patients who received massive transfusions following blunt trauma, defined as the administration of ≥ 10 units of pRBC within 24 hours. The FFP-to-pRBC and PC-to-pRBC ratios were categorised as 0–0.5, 0.5–1, 1–1.5, 1.5–2, and > 2. Multivariate logistic regression analysis was performed to analyse the association between these ratios and in-hospital survival rates. Unsupervised agglomerative clustering was used to identify distinct clinical phenotypes. Results Among 2,849 eligible patients, an FFP-to-pRBC ratio of 1–1.5 was associated with significantly higher in-hospital survival compared to a ratio of 0.5–1 (adjusted odds ratio [OR] = 1.46; 95% confidence interval [CI], 1.12–1.92; P = 0.006). Similarly, a PC-to-pRBC ratio of 1.5–2 was associated with higher survival compared to a ratio of 0.5–1 (adjusted OR = 1.62; 95% CI, 1.00–2.69; P = 0.053). Patients were categorized into three phenotypes: truncal trauma with shock (70.3%), moderate head and extremity trauma (11.8%), and severe head trauma with consciousness disturbances (17.9%). In the truncal trauma with shock phenotype, FFP-to-pRBC ratios of 1–1.5 (adjusted OR = 1.56; 95% CI, 1.12–2.20; P = 0.010) and > 2 (adjusted OR = 2.32; 95% CI, 1.14–5.10; P = 0.027) were associated with improved survival. Conclusions Higher FFP-to-pRBC (1–1.5) and PC-to-pRBC (1.5–2) ratios were associated with improved survival. Higher FFP-to-pRBC ratios were particularly beneficial for truncal trauma with shock phenotype.
- Open Access
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e037652
Effectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation
Background: It is unclear whether an intra‐aortic balloon pump (IABP) or percutaneous ventricular assist device (Impella) in combination with extracorporeal membrane oxygenation (ECMO) is better. Methods: Using the Japanese Diagnosis Procedure Combination database from September 2016 to March 2022, we identified inpatients who received an Impella or IABP in combination with ECMO (ECPella or ECMO+IABP group, respectively). The primary outcome was in‐hospital mortality, and the secondary outcomes included the length of hospital stay, length of ECMO, total hospitalization cost, complications, and durable mechanical circulatory support implantations. Propensity score matching was performed to compare the outcomes between the groups. Results: Of 14 319 eligible patients, 590 (4.1%) received ECPella and 13 729 (96%) received ECMO+IABP. The mean age of patients was 65 years, 77% were men, and 57% had acute coronary syndrome. After propensity score matching, the patient characteristics were well balanced between the groups. The 14‐day mortality rate was lower in the ECPella group than in the ECMO+IABP group (28.0% versus 36.8%; risk difference, −8.2% [95% CI, −13.8 to −2.7]), whereas there was no significant difference in in‐hospital mortality between the groups (58.3% versus 56.6%; risk difference, 2.4% [95% CI, −3.5 to 8.2]). The ECPella group had a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than the ECMO+IABP group. Conclusions: This nationwide inpatient database study showed no significant difference in in‐hospital mortality between the groups, but ECPella was associated with a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than ECMO+IABP.
- 4 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (3) , e037652
Open AccessEffectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation
Background: It is unclear whether an intra‐aortic balloon pump (IABP) or percutaneous ventricular assist device (Impella) in combination with extracorporeal membrane oxygenation (ECMO) is better. Methods: Using the Japanese Diagnosis Procedure Combination database from September 2016 to March 2022, we identified inpatients who received an Impella or IABP in combination with ECMO (ECPella or ECMO+IABP group, respectively). The primary outcome was in‐hospital mortality, and the secondary outcomes included the length of hospital stay, length of ECMO, total hospitalization cost, complications, and durable mechanical circulatory support implantations. Propensity score matching was performed to compare the outcomes between the groups. Results: Of 14 319 eligible patients, 590 (4.1%) received ECPella and 13 729 (96%) received ECMO+IABP. The mean age of patients was 65 years, 77% were men, and 57% had acute coronary syndrome. After propensity score matching, the patient characteristics were well balanced between the groups. The 14‐day mortality rate was lower in the ECPella group than in the ECMO+IABP group (28.0% versus 36.8%; risk difference, −8.2% [95% CI, −13.8 to −2.7]), whereas there was no significant difference in in‐hospital mortality between the groups (58.3% versus 56.6%; risk difference, 2.4% [95% CI, −3.5 to 8.2]). The ECPella group had a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than the ECMO+IABP group. Conclusions: This nationwide inpatient database study showed no significant difference in in‐hospital mortality between the groups, but ECPella was associated with a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than ECMO+IABP.
- Open Access
- 25 June 2024
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 91 (3) , 316-321
Association between Postoperative Adjuvant Vasodilator Therapy and In-Hospital Mortality for Non-Occlusive Mesenteric Ischemia: A Nationwide Observational Study
Background: Although several clinical guidelines recommend vasodilator therapy for non-occlusive mesenteric ischemia (NOMI) and immediate surgery when bowel necrosis is suspected, these recommendations are based on limited evidence. Methods: In this retrospective nationwide observational study, we used information from the Japanese Diagnosis Procedure Combination inpatient database from July 2010 to March 2018 to identify patients with NOMI who underwent abdominal surgeries on the day of admission. We compared patients who received postoperative vasodilator therapy (vasodilator group) with those who did not (control group). Vasodilator therapy was defined as venous and/or arterial administration of papaverine and/or prostaglandin E1 within 2 days of admission. The primary outcome was in-hospital mortality. Secondary outcomes included the prevalence of additional abdominal surgery performed ≥3 days after admission and short bowel syndrome. Results: We identified 928 eligible patients (149 in the vasodilator group and 779 in the control group). One-to-four propensity score matching yielded 149 and 596 patients for the vasodilator and control groups, respectively. There was no significant difference in in-hospital mortality between the groups (control vs. vasodilator, 27.5% vs. 30.9%; risk difference, 3.4%; 95% confidence interval, −4.9 to 11.6; p=0.42) and no significant difference in the prevalences of abdominal surgery, bowel resection ≥3 days after admission, and short bowel syndrome. Conclusions: Postoperative vasodilator use was not significantly associated with a reduction in in-hospital mortality or additional abdominal surgery performed ≥3 days after admission in surgically treated NOMI patients.
- 25 June 2024
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 91 (3) , 316-321
Open AccessAssociation between Postoperative Adjuvant Vasodilator Therapy and In-Hospital Mortality for Non-Occlusive Mesenteric Ischemia: A Nationwide Observational Study
Background: Although several clinical guidelines recommend vasodilator therapy for non-occlusive mesenteric ischemia (NOMI) and immediate surgery when bowel necrosis is suspected, these recommendations are based on limited evidence. Methods: In this retrospective nationwide observational study, we used information from the Japanese Diagnosis Procedure Combination inpatient database from July 2010 to March 2018 to identify patients with NOMI who underwent abdominal surgeries on the day of admission. We compared patients who received postoperative vasodilator therapy (vasodilator group) with those who did not (control group). Vasodilator therapy was defined as venous and/or arterial administration of papaverine and/or prostaglandin E1 within 2 days of admission. The primary outcome was in-hospital mortality. Secondary outcomes included the prevalence of additional abdominal surgery performed ≥3 days after admission and short bowel syndrome. Results: We identified 928 eligible patients (149 in the vasodilator group and 779 in the control group). One-to-four propensity score matching yielded 149 and 596 patients for the vasodilator and control groups, respectively. There was no significant difference in in-hospital mortality between the groups (control vs. vasodilator, 27.5% vs. 30.9%; risk difference, 3.4%; 95% confidence interval, −4.9 to 11.6; p=0.42) and no significant difference in the prevalences of abdominal surgery, bowel resection ≥3 days after admission, and short bowel syndrome. Conclusions: Postoperative vasodilator use was not significantly associated with a reduction in in-hospital mortality or additional abdominal surgery performed ≥3 days after admission in surgically treated NOMI patients.
- Open Access
Assessing the Performance of Zero-Shot Visual Question Answering in Multimodal Large Language Models for 12-Lead ECG Image Interpretation
Large Language Models (LLM) are increasingly multimodal, and Zero-Shot Visual Question Answering (VQA) shows promise for image interpretation. If zero-shot VQA can be applied to a 12-lead electrocardiogram (ECG), a prevalent diagnostic tool in the medical field, the potential benefits to the field would be substantial. This study evaluated the diagnostic performance of zero-shot VQA with multimodal LLMs on 12-lead ECG images. The results revealed that multimodal LLM tended to make more errors in extracting and verbalizing image features than in describing preconditions and making logical inferences. Even when the answers were correct, erroneous descriptions of image features were common. These findings suggest a need for improved control over image hallucination and indicate that performance evaluation using the percentage of correct answers to multiple-choice questions may not be sufficient for performance assessment in VQA tasks.
Open AccessAssessing the Performance of Zero-Shot Visual Question Answering in Multimodal Large Language Models for 12-Lead ECG Image Interpretation
Large Language Models (LLM) are increasingly multimodal, and Zero-Shot Visual Question Answering (VQA) shows promise for image interpretation. If zero-shot VQA can be applied to a 12-lead electrocardiogram (ECG), a prevalent diagnostic tool in the medical field, the potential benefits to the field would be substantial. This study evaluated the diagnostic performance of zero-shot VQA with multimodal LLMs on 12-lead ECG images. The results revealed that multimodal LLM tended to make more errors in extracting and verbalizing image features than in describing preconditions and making logical inferences. Even when the answers were correct, erroneous descriptions of image features were common. These findings suggest a need for improved control over image hallucination and indicate that performance evaluation using the percentage of correct answers to multiple-choice questions may not be sufficient for performance assessment in VQA tasks.
- Open Access
- 6 March 2024
- Published by Elsevier in Annals of Intensive Care
- Vol. 14 (1) , 35-10
Association between pupillary examinations and prognosis in patients with out-of-hospital cardiac arrest who underwent extracorporeal cardiopulmonary resuscitation: a retrospective multicentre cohort study
- 6 March 2024
- Published by Elsevier in Annals of Intensive Care
- Vol. 14 (1) , 35-10
Open AccessAssociation between pupillary examinations and prognosis in patients with out-of-hospital cardiac arrest who underwent extracorporeal cardiopulmonary resuscitation: a retrospective multicentre cohort study
- Open Access
- 8 February 2024
- Published by Elsevier in Resuscitation Plus
- Vol. 17, 100574
Factors associated with favourable neurological outcomes following cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A retrospective multi-centre cohort study
- 8 February 2024
- Published by Elsevier in Resuscitation Plus
- Vol. 17, 100574
Open AccessFactors associated with favourable neurological outcomes following cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A retrospective multi-centre cohort study